Marimed (MRMD) COO Timothy Shaw Receives RSUs; Withholds 3,459 Shares

What Happened
Timothy Shaw, Chief Operating Officer of Marimed, had 9,982 restricted stock units (RSUs) convert into common shares on April 2, 2026. The conversion was reported as an exercise/conversion of a derivative (code M) at $0.00 per share. To satisfy tax withholding, the issuer withheld 3,459 shares (code F) at $0.07 per share for a total withholding of $239. Net new shares received by Shaw from this vesting event: 6,523 shares (9,982 issued minus 3,459 withheld).

Key Details

• Transaction date: April 2, 2026; Form 4 filed April 3, 2026 (timely filing).
• Conversion: 9,982 shares acquired via RSU conversion (M) at $0.00 per share.
• Tax withholding: 3,459 shares disposed (F) at $0.07 per share; total withholding = $239.
• Net shares added to insider: 6,523 shares.
• Shares owned after transaction: Not specified in the filing.
• Notable footnotes:
  • F1/F2: RSUs convert one-for-one; shares were withheld to satisfy tax withholding.
  • F3: A trust holds certain shares for the benefit of the reporting person’s children; the reporting person disclaims beneficial ownership of those trust shares.
  • F4: The RSU grant was originally made April 2, 2024; remaining portions of the grant vest on Oct 2, 2026 (9,981 RSUs) and Apr 2, 2027 (9,982 RSUs).

Context

• This was an RSU vesting event (the RSUs converted into shares), not an open-market purchase or sale by the insider. The withholding of shares to cover tax obligations is a common, administrative “cashless” aspect of vesting and does not necessarily signal the insider’s view of the company’s stock.